JPRN-jRCT2080221375未知2 期
An early phase 2 study of NST-141 in patients with atopic dermatitis
TAIHO PHARMACEUTICAL CO.,LTD, NIPPON SHINYAKU CO.,LTD0 个研究点目标入组 120 人开始时间: 2011年2月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •(1) Signed, written informed consent.
- •(2) Able to be treated as an outpatient.
- •(3) Diagnosis of atopic dermatitis by Japanese dermatological association criteria.
排除标准
- •(1) Serious asthma.
- •(2) Hepatic, renal, heart or hematological disease considered to be clinically significant by the Investigator's opinion.
- •(3) Infection of skin with antimicrobial use.
研究者
相似试验
已完成
2 期
ate Phase II Study of TS-142 in Patients with InsomniaInsomnia DisorderJPRN-jRCT2080225269Taisho Pharmaceutical Co., Ltd.160
已完成
2 期
Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.on-small cell lung cancerJPRN-UMIN000000817agasaki Thoracic Oncology Group32
未知
2 期
A M117101 phase II study in patients with primary palmar hyperhidrosisprimary palmar hyperhidrosisJPRN-jRCT2080222374Maruho Co.,Ltd.
未知
2 期
Phase II clinical study of TY-0201 in patients with chronic heart failureChronic heart failureJPRN-jRCT2080222593TOA EIYO LTD.40
未知
1 期
Phase 1/2 study of NS-065/NCNP-01 in patients with Duchenne muscular dystrophyDuchenne muscular dystrophyJPRN-jRCT2080223236IPPON SHINYAKU CO., LTD.16